SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-060610
Filing Date
2021-11-18
Accepted
2021-11-18 17:01:03
Documents
42
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_pasitheatherap.htm   iXBRL 10-Q 442534
2 CERTIFICATION f10q0921ex31-1_pasithea.htm EX-31.1 13013
3 CERTIFICATION f10q0921ex31-2_pasithea.htm EX-31.2 13652
4 CERTIFICATION f10q0921ex32-1_pasithea.htm EX-32.1 5304
5 CERTIFICATION f10q0921ex32-2_pasithea.htm EX-32.2 5607
  Complete submission text file 0001213900-21-060610.txt   2578017

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ktta-20210930.xsd EX-101.SCH 27750
7 XBRL CALCULATION FILE ktta-20210930_cal.xml EX-101.CAL 18697
8 XBRL DEFINITION FILE ktta-20210930_def.xml EX-101.DEF 138616
9 XBRL LABEL FILE ktta-20210930_lab.xml EX-101.LAB 275603
10 XBRL PRESENTATION FILE ktta-20210930_pre.xml EX-101.PRE 146435
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_pasitheatherap_htm.xml XML 208549
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40804 | Film No.: 211425165
SIC: 2834 Pharmaceutical Preparations